Navigation Links
Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
Date:11/9/2010

ific body systems after treatment with epratuzumab.  Improvements were particularly prominent in cardiorespiratory and neuropsychiatric systems in which symptom improvements are often difficult to achieve.

These results demonstrated that in a patient population with predominantly high or severe disease activity, differences in responder rates between the epratuzumab 600mg weekly and 1200mg every other week groups, and the placebo group was observed as early as week 12, with the emergence of improvements apparent in week 8.

In two previous phase II randomized controlled trials, epratuzumab treatment resulted in clinically meaningful reduced disease activity, improved health-related quality of life (HRQoL) measurements and reduced reliance on corticosteroids compared to placebo treatment in patients with active moderate and severe SLE.

"We are pleased by the repeated consistency of symptom improvement demonstrated by epratuzumab in all our clinical studies to date and we look forward to confirming these results in our phase 3 studies due to start later this year," said Prof. Dr. Iris Loew-Friedrich, Chief Medical Officer of UCB. She added, "Achieving a BILAG improvement, especially at an early timepoint seen in EMBLEM™, is a hopeful sign of the drug's future potential."

Epratuzumab is a humanized monoclonal antibody targeting CD22 and modulating B cell activity.  Although the exact role of CD22 is not fully understood, it is considered to be a regulator of B cell function. B cells are known to contribute to SLE by producing antibodies against the body's own cells and tissues, causing the immune system to turn on itself, resulting in inflammation and tissue damage. Epratuzumab is an anti-B-cell therapeutic, because of its ability to modulate B cell function without depleting a large portion of these lymphocytes.

* This study was not powered to detect statistical differences between treatment arms (p values were no
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- On August 5, 2015, the U.S. District Court for ... motions to dismiss securities class action claims against Galena ... its directors. The class actions allege that the individual ... artificially inflate Galena,s stock price, and during an eighteen ... sold massive amounts of their personally-held shares. ...
(Date:8/31/2015)... FLINT, Mich. , Aug. 31, 2015  Diplomat Pharmacy, ... pharmacy, has announced that Phil Hagerman , Chairman & ... four upcoming investor conferences. Mr. Hagerman and ... 2015 Healthcare Conference in Boston on ... Mr. Hagerman and Mr. Whelan are also scheduled to participate ...
(Date:8/31/2015)...  AMRI (NASDAQ: AMRI ) and Saneca ... on the development, manufacture and marketing of a ... collaboration combines Saneca,s strength in extracting opiates from ... manufacturing controlled substance APIs with AMRI,s U.S. assets ... these facilities. The collaboration will also capitalize on ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2Diplomat to Participate in Upcoming Investor Conferences 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4
(Date:8/31/2015)... ... , ... The Sundance Film Festival award winning documentary “Alive Inside” is being ... a social worker who advocates for the use of music therapy for dementia patients ... residents in health care centers who may have lost a spark in life and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Garden State Urology ... the result of a merger of five of the busiest urology practices in ... provide more cost-effective and higher quality care than they did individually. Their ...
(Date:8/31/2015)... ... , ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and ... Michael Betsy graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He ... sports in his senior year. He was inducted into the National Honor Society as ...
(Date:8/31/2015)... TN (PRWEB) , ... August 31, 2015 , ... ... how it may be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination ... the most common cause of visual impairment among children, affecting approximately 2 to 3 ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... ... print and digital marketing communications company announced today that it has officially launched ... DP President, the new website and brand refresh are more closely aligned with ...
Breaking Medicine News(10 mins):Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
... Group, Inc., the parent company of Ruth,s Chris Steak House, ... Broad Street Ruth,s Chris Steak House to Tulane University for ... Center, a neighborhood-based medical home that will provide care to ... The building will honor the restaurant company,s founder, ...
... , HARRISBURG, Pa., July 10 Hunters will see similar ... of which open Sept. 1, as part of Pennsylvania,s 2009-10 ... Director Carl G. Roe. , , Dove hunters, once ... season. During the first season (Sept. 1-26), hunting will start ...
... Texas, July 10 Nearly 500 emaciated, parasite-infested dogs were ... July 7. The dogs, confined in filthy, overcrowded conditions, ... a bill in the Texas Legislature that would have required ... the state and meet at least a minimal level of ...
... NEW YORK, July 10 Looking to reinforce its positioning as ... an aggressive new advertising campaign that speaks to New Yorkers as ... Carrying the tagline, "Your city. Your drugstore. Duane Reade", ... cars and buses, as well as on phone kiosks, billboards and ...
... HAVEN, Conn., July 10 The American people continue to move to ... by the Knights of Columbus and Marist Poll. , , The ... as pro-life than as pro-choice, and that the vast majority of Americans ... , 86% ...
... ... (CBCA) today announced a strategic partnership with Bravo Wellness, LLC to deliver results-based incentives ... ... a strategic partnership with Bravo Wellness, LLC to deliver results-based incentives for wellness programs., ...
Cached Medicine News:Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 2Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 3Health News:Dove and Early Canada Goose Seasons to Begin Sept. 1; Game Commission Posts Avian Influenza Information on Website 2Health News:Dove and Early Canada Goose Seasons to Begin Sept. 1; Game Commission Posts Avian Influenza Information on Website 3Health News:Dove and Early Canada Goose Seasons to Begin Sept. 1; Game Commission Posts Avian Influenza Information on Website 4Health News:Dove and Early Canada Goose Seasons to Begin Sept. 1; Game Commission Posts Avian Influenza Information on Website 5Health News:Dove and Early Canada Goose Seasons to Begin Sept. 1; Game Commission Posts Avian Influenza Information on Website 6Health News:Dove and Early Canada Goose Seasons to Begin Sept. 1; Game Commission Posts Avian Influenza Information on Website 7Health News:Texas Humane Legislation Network Calls for Puppy Mill Crackdown 2Health News:Duane Reade Dispenses a Large Dose of Marketing, as it Strengthens its Hometown Connection 2Health News:Duane Reade Dispenses a Large Dose of Marketing, as it Strengthens its Hometown Connection 3Health News:New Poll Shows Americans Continuing to Move Toward Pro-Life Position on Abortion 2Health News:CBCA Administrators, Inc. Announces Partnership with Bravo Wellness 2
Pre-Loaded with a Stylet., ,Available Cuffed or Uncuffed, pre-loaded with a stylet to facilitate quick intubations....
Nasal soft cuffed endotracheal tubes designed and constructed especially for long-term nasal intubations....
... Disposable, sterile and individually wrapped, ... type Introducer will assist in the ... especially when the laryngeal opening is ... at 10cm intervals as well as ...
Indications For Usage: ,Used to stabilize/secure orally intubated tracheal tubes without using adhesive tapes....
Medicine Products: